Insider Transaction Report

This filing details a Form 4 document for Alan Grujic, a director at GUIDED THERAPEUTICS INC. On March 10, 2026, Grujic acquired 110,000 stock options with an exercise price of $0.29 per share. These options vest over time, with one-fourth vesting immediately and the remainder vesting monthly until March 9, 2029. The underlying security is Common Stock. The transaction is classified as an acquisition of securities.